EASTONBIOPHARMACEUTICALS(SH:688513) Xin Lang Cai Jing·2025-09-08 03:31Company Overview - Yuan Dong Bio-pharmaceutical Co., Ltd. is located in Chengdu, Sichuan Province, established on June 1, 2009, and listed on September 2, 2020. The company specializes in the research, production, and sales of chemical raw materials and chemical drug formulations [1] - The main revenue composition includes: 78.75% from formulation sales, 9.22% from raw material sales, 6.79% from technical services and transfers, 4.01% from CMO/CDMO, and 1.22% from other sources [1] Stock Performance - On September 8, Yuan Dong Bio's stock fell by 5.19%, trading at 57.22 CNY per share, with a transaction volume of 78.536 million CNY and a turnover rate of 0.76%. The total market capitalization is 10.101 billion CNY [1] Fund Holdings - According to data from the top ten holdings of funds, one fund under Industrial Bank, the Industrial Bank Healthcare A (011466), holds 699,200 shares of Yuan Dong Bio, accounting for 7.46% of the fund's net value, making it the largest holding [2] - The fund has reported a floating loss of approximately 2.1886 million CNY as of the latest data [2] Fund Manager Information - The fund manager of Industrial Bank Healthcare A is Chen Xu, who has been in the position for 4 years and 186 days. The total asset size of the fund is 385 million CNY, with the best return during the tenure being -10.59% and the worst return being -12.57% [3]